Two previously published trials (ARDS et Curarisation Systematique and Reevaluation of Systemic Early Neuromuscular Blockade) presented equivocal evidence on the effect of neuromuscular blocking agent infusions in patients with acute respiratory distress syndrome.

SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for ARD

The Society of Critical Care Medicine (SCCM) Podcast features in-depth interviews with leaders in critical care. Experts discuss hot topics in intensive care with perspectives from all members of the critical care team. Guests include authors from SCCM’s peer-reviewed journals, Critical Care Medicine, Pediatric Critical Care Medicine, and Critical Care Explorations, as well as thought leaders within the field. This is a new and updated channel, formerly known as the iCritical Care Podcast All Audio Channel.

Share SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for ARD

Sign up to save your podcasts

SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for ARD

SCCM Pod-440 Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for ARD